Data and Safety Monitoring Plan
The data and safety monitoring plan is included with the grant application for clinical studies. It establishes: the overall framework for data and safety monitoring, how adverse events will be reported to the Institutional Review Board and the National Institutes of Health (NIH), when the study should be continued or stopped, and (when appropriate) how the NIH guidelines and Food and Drug Administration regulations for investigational medicines and investigational devices will be satisfied.
